Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: DeLuca, Stephanie C. | Case-Smith, Jane | Stevenson, Richard | Ramey, Sharon Landesman
Affiliations: Department of Occupational Therapy, The University of Alabama, Birmingham, AL, USA | Occupational Therapy Division, Ohio State University, Columbus, OH, USA | Department of Pediatrics, The University of Virginia, Charlottesville, VA, USA | Virginia Tech Carilion Research Institute Virginia Tech, Roanoke, VA, USA
Note: [] Corresponding author: Stephanie DeLuca, 347 School of Health Professions, UAB, 1530 3rd Avenue South, Birmingham, AL 35294, USA. Fax: +1 205 975 2380; E-mail: sdeluca@uab.edu
Abstract: Objective: To compare effects of 2 dosage levels of constraint-induced movement therapy (CIMT) for children with hemiplegic cerebral palsy (CP). We hypothesized that high-dosage CIMT would produce larger benefits than moderate-dosage. Methods: Three sites enrolled a total of 18 children (6 children per site from 3–6 years) with unilateral CP. Children were randomly assigned to CIMT for 21 days for either 6 hours/day (high-dosage=126 hours) or 3 hours/day (moderate-dosage=63 hours); both groups wore a long-arm cast. Evaluators (blind to dosage) assessed children 1-week prior, then 1-week and 1-month after treatment with the Assisting Hand Assessment (AHA), The Quality of Upper Extremity Skills Test (QUEST) Dissociated Movement and Grasp sections, the Shriners Hospital Upper Extremity Evaluation (SHUEE), and the Pediatric Motor Activity Log (PMAL). Results: All children responded well to casting and received the full intended dosage. Both groups showed statistically significant gains on the AHA, QUEST, SHUEE, and PMAL. Effect sizes ranged from 0.36–0.79. Overall, both groups showed comparable improvements at 1-week and 1-month post-treatment. Conclusions: Pediatric CIMT at both moderate and high dosages produced positive effects across multiple reliable, valid outcome measures. The findings refuted the hypothesis of differential dosage benefits. Future research should address long-term effects, enroll larger and more diverse samples, and assess lower dosages to ascertain a minimal-efficacy threshold.
Keywords: Cerebral palsy, pediatric constraint-induced movement therapy (CIMT), randomized controlled trial, upper-limb dysfunction, hemiplegia, rehabilitation
DOI: 10.3233/PRM-2012-0206
Journal: Journal of Pediatric Rehabilitation Medicine, vol. 5, no. 2, pp. 133-142, 2012
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl